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Recent RNA sequencing studies have revealed that most of the human genome is transcribed, but very
little of the total transcriptomes has the ability to encode proteins. Long non-coding RNAs (lncRNAs) are
non-coding transcripts longer than 200 nucleotides. Members of the non-coding genome include
microRNA (miRNA), small regulatory RNAs and other short RNAs. Most of long non-coding RNA
(lncRNAs) are poorly annotated. Recent recognition about lncRNAs highlights their effects in many
biological and pathological processes. LncRNAs are dysfunctional in a variety of human diseases varying
from cancerous to non-cancerous diseases. Characterization of these lncRNA genes and their modes of
action may allow their use for diagnosis, monitoring of progression and targeted therapies in various
diseases. In this review, we summarize the functional perspectives as well as the mechanism of action of
lncRNAs.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
The overwhelming use of technologies and new discoveries has
led to the understanding of functional properties of what was once
considered as junk DNA. The International Human Genome
Sequencing Consortium 2004 surprised everyone after revealing
that there are only 20,000 protein-coding genes in the human
genome, that is just about >2% of the total genomic sequences.
Through the extensive annotation efforts, some dedicated consor-
tiums such as the ENCODE project, have broadened our knowledge
of what lies in the dark recesses of the genome [1]. These ﬁndings in
relation to previous studies have underscored the pervasiveness of
genome transcription [2,3], and it became clear that nonprotein-
coding regions too have various functions and regulatory roles. A
mere number of protein-coding genes probably can't explain the
organizational complexity of organisms, as there are other less
complex eukaryotes with a more or less similar number of protein-
coding genes (e.g., Caenorhabditis elegans). This increasedad).
ing by Elsevier B.V. on behalf of Ke
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6.11.002complexity may be explained by pre-mRNA splicing of protein-
coding transcripts and post-translational modiﬁcation of proteins,
which increase the diversity and functionality of the proteome. The
human genome sequencing has provided an opportunity for the
systematic survey of genomic regions for their biological activity. As
a ﬁrst logical proxy for activity, many groups began their quest by
mapping observed transcriptional events in the genome [4,5]. A
project called FANTOM3 identiﬁed approximately 35,000 non-
coding transcripts from approximately 10,000 distinct loci
bearingmany signatures of mRNAs, including capping, splicing, and
poly-adenylation, but has little or no open reading frames (ORF) [6].
Thousands of long non-coding RNA (lncRNA) transcripts were
identiﬁed that did not appear to be coding for proteins due to these
early efforts [7,8].
LncRNAs are up to ~100 kilobases (kb) long, more speciﬁcally
their nucleotide span range from 200 nt to 100 kilobases (kb). These
are mRNA-like transcripts, but lack stable open reading frames. Like
other protein coding genes, lncRNAs are probably transcribed by
RNA polymerase II (RNA pol II) and are polyadenylated [9,10].
Generally, the extent or levels of expression of lncRNAs appear to be
lower than protein-coding genes [11e14], and speciﬁc to the tissues
[15]. Although the function of most of the lncRNAs is unknown, theAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
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their role in regulation of gene expression at transcriptional as well
as at post-transcriptional level in development, differentiation, and
human diseases, that could be negative or positive [16e18]. It has
been reported that many lncRNAs functions as key regulators of
translational output (also transcriptional) and therefore affect cell
identity and function [19e22]. In a short period, lncRNAs have
emerged as legitimate, major new class of genes, as more and more
functions are being attributed to them. In the near future, more
functions associated with them will emerge.
2. Mechanism of action
2.1. LncRNAs as chromatin regulators
The number of lncRNAs with described functions is steadily
increasing, and most of the reports revolve around their regulatory
capacity. LncRNAs often function as important cis and trans-acting
modulators for the expression of protein-coding genes [23,24].
LncRNAs can mediate epigenetic modiﬁcation by recruiting
chromatin-remodelling complex to a speciﬁc chromatin locus
(Fig. 1A). At least 38% of the lncRNAs present in several tissues bind
to the polycomb repressive complex 2 or the chromatin modifying
proteins, CoREST and SMCX [24]. Others bind to trithoraxFig. 1. LncRNA-mediated transcriptional regulation. Long non-coding RNAs (lncRNAs; red so
with and recruitment of chromatin-modifying enzymes (e.g., histone methylases, acetylases
enzymes leads to activation or repression of local genes. (B) Interaction with other RNA-bin
promote transcription by recruiting key proteins to the target gene promoters or repress gen
functions and help to change the chromatin architecture and recruit transcriptional machin
also involved in the repression of some pro-apoptotic genes, such as FAS and BIK, by actin
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(2016), http://dx.doi.org/10.1016/j.ncrna.2016.11.002chromatin-activating complexes and/or activated chromatin [25].
The well-characterized lncRNAs, ANRIL, XIST, HOTAIR and
KCNQ1OT1 are able to recruit epigenetic modiﬁers to speciﬁc loci
for reprogramming the chromatin state. For example, KCNQ1OT1
binds to PRC2 and the methyl-transferase G9A (also known as
EHMT2), whereas ANRIL binds to PRC1 and PRC2 [26,27]. HOTAIR
and other lncRNAs function as scaffolds (Fig. 1B) coordinate the
targeting of speciﬁc repressive histone modifying complexes to
target loci [26]. However, within this framework, the detailed
mechanism of how speciﬁc DNA regions are targeted by lncRNAs
remains unclear. An example of such principle approaches together
is the XIST locus that controls the X chromosome dosage
compensation. XIST, in many ways can be considered as a model
example of lncRNA biology, and the dissection of its mechanism of
action can serve as a guide for deeper and thorough future lncRNA
studies. Principally, X chromosome inactivation is due to ablation of
the DNA and promoter of XIST [27,28], yet such models can't un-
dermine the effect of the local act of transcription.
2.2. Transcriptional regulation
Long non-coding RNAs act as co-factors to modify the activity of
transcriptional factor. For example, the ncRNA Evf2 is transcribed
from conserved distal enhancer and recruits the transcriptionlid lines) regulate gene transcription through three main mechanisms: (A) Interaction
, and deacetylases) to the target gene locus. Modulation of the chromatin state by these
ding factors such as hnRNPs to form RNAeprotein complexes (RNPs). RNPs can either
e transcription by binding to existing gene repressors. (C) LncRNAs also have enhancer
ery proteins to adjacent target gene locus to promote its transcription. (D) LncRNAs are
g as a decoy for the transcription factor (NF-YA).
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adjacent protein-coding genes [29]. Various developmental genes
are regulated in a similar fashion by transcribing the enhancers in
the cells in which they are active [30]. LncRNAs can modify RNA
polymerase (RNAP) II activity by interplaying with the initiation
complex to steer promoter choice e.g., in the humans transcription
of a ncRNA from an upstream region of the dihydrofolate reductase
(DHFR) locus to form a triplex in the major promoter of DHFR in-
hibits the binding of the transcriptional co-factor TFIID31. This
could be a general mechanism for controlling the usage of the
promoter, as thousands of these triplex structures exist in eukary-
otic chromosomes [31]. Long lncRNAs may also affect global
changes by interacting with some basic components of the RNAP II-
dependent transcription machinery. LncRNAs interacting with
RNAP II machinery are primarily transcribed by RNAP III, thereby
delinking their expression from the RNAP II-dependent transcrip-
tion reaction they regulate. For example, transcription of Alu ele-
ments in response to heat shock, they bind tightly to RNAP II to rule
out the formation of active pre-initiation complexes [32]. Alu ele-
ments can independently mediate polymerase binding and
repression by their respective domain interaction. Due to their
abundance and distribution in the mammalian genome, these
functional domains might have been co-operated into other
ncRNAs during evolution [33].
2.3. Post-transcriptional regulation
The ability of ncRNAs to identify complementary sequences al-
lows some speciﬁc interactions capable of regulating post-
transcriptional processing of mRNAs like capping, splicing, edit-
ing, transport, translation, degradation, and stability at various
control sites. For example, MALAT1 affects alternate splicing by
interacting with splicing factors. Another lncRNA, Gomafu/MIAT,
which is localized to a nuclear domain and has a neuron-speciﬁc
expression, may block spliceosome formation and affect the
mRNA splicing by sequestering splicing factor 1 (SF1) [34,35]. The
NAT lncRNAs also plays an essential role in regulating mRNA dy-
namics (Fig. 1D). About 61e72% of all transcribed regions possess
lncRNAs in antisense orientation (NATs) [36]. Unlike classical NAT
lncRNAs to the imprinting genes (Tsix, Air, HOTAIR, and Evf-2)
which are responsible for recruiting repressor complexes like
PRC2 to the target site, certain NATs result in RNA duplexes to
inhibit cis-regulatory elements, leading to an alternate splicing
pattern of the paired gene. For example, the Zeb2/Sip1 NAT com-
plementary binds to the 50 splice site of an intron in the 50-UTR of
the zinc ﬁnger Hox mRNA Zeb2, which plays a crucial role in
epithelial-mesenchymal transition (EMT). Expression of the Zeb2
NAT upon EMTmasks the splice site, hence preventing spliceosome
action. Subsequently the translation machinery can then recognize
and bind to an internal ribosome entry site (IRES), resulting in more
efﬁcient Zeb2 translation.
3. LncRNAs: a functional perspective
Though they are different from mRNAs exported to the cyto-
plasm for translation, few lncRNAs are known to be restrained in
certain sub-nuclear compartments [37e39], which suggest poten-
tial functions in these compartments.
3.1. X chromosome inactivation
Epigenetic regulation of allelic expression (process of dosage
compensation and genomic imprinting) is the best-studied func-
tion of lncRNAs. XCI (X chromosome inactivation) compensates the
imbalance between XX and XY with respect to X-linked genes byPlease cite this article in press as: S.A. Bhat, et al., Long non-coding RNAs:
(2016), http://dx.doi.org/10.1016/j.ncrna.2016.11.002inactivation of one of the X chromosomes in females through
hetero-chromatinization [40]. Two different types of XCIs occur in
placental mammals, the ﬁrst one is the imprinted XCI, in the em-
bryo, where the paternal X chromosome is always inactivated and
another type is the random XCI, which occurs in the inner cell mass
where epigenetic markers have been silenced after embryo im-
plantation [41]. In random XCI, either the paternal or the maternal
X chromosome is randomly inactivated, producing a mosaic female.
XCI in placental mammals is regulated by a cluster of lncRNA loci
which is known as the X-inactivation centre (Xic) [42]. The Xi-
speciﬁc transcript (Xist) is highly expressed from Xi (X inactive)
during the onset of XCI, but not fromXa (Xactive) chromosome. Xist
RNA recruits silencing factors like Polycomb repressive complex 2
(PRC2) [43] by forming a “Xist cloud” around the X chromosome
[44]. As it turns out, Xist is regulated by other lncRNAs. Tsix, which
is transcribed in antisense orientation from a promoter down-
stream of Xist, is expressed at a higher level before initiating XCI
and then goes silent from the future Xi chromosome, but persists
on the presumptive Xa chromosome, thus exhibiting the reverse
pattern as Xist expression. Tsix has a role in coordinating X chro-
mosome pairing to bring epigenetic asymmetry within the Xist
locus and to downregulate Xist by different mechanisms [45].
3.2. Regulation of allelic expression: genomic imprinting
LncRNAs also play their role in genomic imprinting by expres-
sion of a gene monoallelically according to its line of descent
[46,47]. Like XCI, imprinting is also controlled by some speciﬁc
genomic loci, known as imprinting control regions. Depending on
parental origins, differentially methylated regions, unmethylated
DNA imprinting control regions (ICRs), result in speciﬁc expression
of nearby lncRNAs genes and suppression of neighbouring genes in
cis [48]. Most of the imprinted clusters are associated with protein
coding genes and some speciﬁc lncRNAs which are inversely
expressed, e.g., Air and Kcnq1ot1/LIT1 (Kcnq1 opposite transcript 1,
or long QT intronic transcript 1) cause suppression of paternally
inherited genes. Precisely, Kcnq1ot1/LIT1 is involved in repression
of several protein-coding genes in cis by interacting with repressive
chromatin-modifying complexes [49,50]. Kcnq1ot1/LIT1 is an
imprinted region with at least eight genes expressed exclusively or
preferentially from the maternal allele [51]. Kcnq1ot1/LIT1 acts as
an organizer on a tissue/lineage-speciﬁc nuclear domain, involving
in epigenetic silencing of the Kcnq1 imprinting control region
[51e54] other examples being Igf2r/Air [26], Dlk1/Gtl2 [27], Nesp/
Nespas/Gnas [55], and the BeckwitheWiedemann syndrome (BWS)
associated Kcnq1/Kcnq1ot1 [56]. These lncRNAs regulate the
expression of imprinted genes by recruiting epigenetic factors, such
as PRC2 and G9a [57]. H19 was one of the ﬁrst lncRNAs to be
identiﬁed and is reported to be the most highly expressed tran-
scripts within the embryo [58]. It is inversely imprinted with Igf2.
However, it has been observed that H19 does not seem to function
as a lncRNAs [59], but acts as miRNA precursor [60].
4. LncRNAs in cancer
Cancer is a condition where gene expression is aberrant. The
study of genetic background of cancer has revealed that the ma-
jority of the cancers are attributed to non-coding regions of the
genome. Recent developments indicate that several cancer loci are
transcribed into lncRNAs and that these transcripts play key roles in
tumorigenesis. LncRNAs contribute to cancer development through
diverse mechanisms. LncRNAs are reported to be implicated in
serial steps of cancer development [61]. These lncRNAs interact
with nucleic material and protein molecules and/or their combi-
nations and act as an essential regulator of chromatin organization,Mechanism of action and functional utility, Non-coding RNA Research
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expression confers the cancer cell potential to initiate tumour
growth, and metastasis. A review demonstrating the roles of
lncRNAs in cancer diagnosis and therapy, reported different
expression proﬁles for numerous lncRNAs in urothelial cancer [62].
Various evidences suggest that most of the lncRNAs result in
epigenetic changes by recruiting various chromatin modifying
agents [63,64], like polycomb repressive complex 2 or the chro-
matin modifying proteins CoREST and SMCX [65]. The best studied
lncRNAs (Table 1); ANRIL, MALAT1, HOTAIR and KCNQ1OT1,
Taurine-upregulated gene 1 (TUG1), LINC00152, RP11-385J1.2 and
TUBA4B which recruit epigenetic modiﬁers to their respective
speciﬁc loci to regulate the chromatin state and their misexpression
are linked to diverse cancers such as ANRIL: prostate cancer,
HOTAIR: breast cancer KCNQ1OT1: colorectal cancer, TUG1:
esophageal cancer, LINC00152: gastric cancer, RP11-385J1.2 and
TUBA4B: non-small cell lung cancer [66e70]. One of the ﬁrst
lncRNAs described to have a functional role in the development of
cancer is the metastasis-associated HOX Antisense Intergenic RNA
(HOTAIR). HOTAIR lncRNAs promotes cancer metastasis by
inducing epigenetic variations in the chromatin state of cancer cells
[71]. The mechanism of action is well demonstrated in Fig. 2. It was
observed to be highly up-regulated in metastatic and primary
breast tumours, about 2000 times over the normal breast tissue.
The upregulation of HOTAIR could be associated with poor prog-
nosis in breast, liver, colorectal, GIT, and pancreatic cancers.
Meanwhile, it may probably contribute to promote the tumour
invasiveness and metastasis [72e77]. A substantial growth of pri-
mary tumours was observed in mouse mammary fat pads by the
grafting cells expressing HOTAIR [78]. Interestingly, certain reports
indicate various lncRNAs emanating from the HOX locus suggesting
its global regulatory role [79]. Taurine-upregulated gene 1 (TUG1)
has shown signiﬁcant over expression in esophageal squamous cell
carcinoma (ESCC) tissues, and in vitro silencing of TUG1 inhibits the
proliferation and migration of ESCC cells [80]. POU3F3 (Linc-POU
class 3 homeobox 3) acts as a regulator in ESCC, which promotes
the methylation of POU3F3 by interacting with EZH2 [67,68].
Another signiﬁcant lncRNA (LINC00152) has been associated with
the development of gastric cancer (GC) and can be used as
biomarker for GC diagnosis [69]. Recent comprehensive studies
have shown that wide range of lncRNAs are signiﬁcantly associated
with non-small cell lung cancer (NSCLC). Important among these,
RP11-385J1.2 and TUBA4B, and are aberrantly over expressed
lncRNAs, thus exhibit an important developmental role in NSCLC
[70]. The MALAT1 gene, or the metastasis-associated lung adeno-
carcinoma transcript 1, is associated with metastatic potential and
is widely expressed in various human tissues [81,82] and was also
found to be up-regulated in various types of cancers like breast,
prostate, colon, liver and uterine cancers [83]. Some lncRNAs are
constituents of macromolecular complexes involved in RNA pro-
cessing. MALAT1 is proposed to be acting at a post-transcriptional
level by controlling the alternative splicing of pre-mRNA mole-
cules. It modulates the activity of serine/arginine (SR) splicingTable 1
LncRNAs in cancer.
S.No. lncRNA Function
1 ANRIL Transcription control by chromatin mod
2 MALAT1 Promotes cancer by controlling the alter
3 HOTAIR Promotes cancer metastasis and progres
4 KNCQ10T1 Promoting cancer progression
5 TUG1 Promoting proliferation, migration, cell
6 LINC00152 Promoting cancer progression
7 RP11-385J1.2 Suppressing proliferation and invasion
8 TUBA4B Promoting proliferation, migration, inva
Please cite this article in press as: S.A. Bhat, et al., Long non-coding RNAs:
(2016), http://dx.doi.org/10.1016/j.ncrna.2016.11.002factors [84]. MALAT1 is up-regulated in various cancer types and is
over-expressed in metastatic cells of lung and colorectal cancers
[85].
Many tumor suppressor genes are known to carry antisense
transcripts [86]. For example, p15, a cyclin-dependent kinase in-
hibitor implicated in leukemia, possesses an antisense transcript,
which silences its transcription in cis and trans by inducing het-
erochromatin formation without changing the DNA methylation in
a Dicer-independent manner [87e90]. It is possible that these
antisense transcripts directly bind and recruit chromatin-
modifying complexes to their associated sense transcripts [91].
In summary, lncRNAs can act through different mechanisms to
regulate cancer state. Although the molecular mechanisms of
various lncRNAs functions are well studied, but their modes of
action mostly remain unclear. A comprehensive study of the
lncRNA mechanism and their functions will aid in better under-
standing of their role in cancer and will open up new therapeutic
possibilities to modulate their function.
4.1. Role of LncRNAs in immunity
The role of non-coding RNAs in the regulation of gene expres-
sion in immune cells is still poorly understood [92]. Reports suggest
their role in T cell development, differentiation, and activation of
adaptive and innate immunity. LncRNAs are reported to be present
in various immune cells like monocytes, macrophages, dendritic
cells, neutrophils, T cells and B cells. The role of lnc-DC in the dif-
ferentiation of monocytes to dendritic cells has been well estab-
lished [93,94]. Many lncRNAs like Lethe [95] and lnc-IL7R [96] have
been reported to possess immune system associated functions.
Moreover, recent reports reveal that the regulatory functions of
many of these lncRNAs are in RNA-protein binding [97,98], chro-
matin remodeling [99, 100] and in interactions with transcriptional
factors and signaling molecules [101] as described in Fig. 1D.
Although the functions of most of the lncRNAs in infections are still
unknown, recent reports suggest that many lncRNAs may be
playing a pivotal role in gene regulation at transcriptional and
posttranscriptional level during innate immune responses. Their
role in gene expression regulation inmacrophages and other innate
immune cells has also been reported. Such discoveries suggest that
lncRNAs may contribute to gene regulatory networks governing
hostepathogen interactions. Similarly, inﬂammatory mediation or
cytokine regulation by lncRNAs is also poorly understood. The
innate immunity is the frontline defense response of a cell. The
Innate immune response is important to the host to defend itself
from the invasion of various pathogenic organisms like bacteria or
viruses. As cells encounter pathogens, an innate immune response
is triggered by the production of inﬂammatory mediators or cyto-
kines through transcription factors, such as API, NF-kB, andmiRNAs
[102, 103]. The innate immune response also triggers adaptive
immune responses by recognizing pathogens by certain speciﬁc
receptors known as TLRs (Toll-like receptors) resulting in the
elimination of the pathogen. It has been found that TLRs are a majorReference
iﬁcations [52]
native splicing of pre-mRNA molecules [67,68,69]
sion through epigenetic variations in the chromatin state [61]
cycle [53,54,66]
[55]
[56]
sion [56]
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Fig. 2. Model of long noncoding RNA (lncRNA) HOX transcript antisense RNA (HOTAIR) regulating expression of HOX genes in trans. LncRNA HOTAIR transcribed from the HOXC
cluster of genes (chromosome no.2) binds PRC2 complex of polycomb-group of proteins and targets it to the HOXD cluster (chromosome no.12) leading to H3K27 methylation and
silencing of neighboring HOXD genes.
S.A. Bhat et al. / Non-coding RNA Research xxx (2016) 1e8 5receptor type for pathogen recognition [104]. Following this ligand
recognition by these receptors, lncRNAs like Nest/tmvpg1
[105,106], IL1b-eRNA [107] and IL1b-RBT46 [108] recruit tran-
scription activators through RNAeprotein complex formation or
remove repressors of transcription, leading to rapid expression of
cytokines. This also involves transcriptional and post-
transcriptional gene regulation via transcription factors (API and
NF-kB, and miRNAs) [109]. Phagocytes such as macrophages and
polymorphonuclear neutrophilic granulocytes (PMNs) represent
the ﬁrst line of defense against invading pathogens. Macrophages
are key components of host defense mechanisms against invading
pathogens. Many lncRNAs were also found to be up-regulated in
macrophages exposed to Toll-like receptor 2 (TLR2) ligands [110]. It
has been found that a large number of lncRNAs are involved in
regulation of interferon stimulated genes (ISG) like PACER[111],
NRON[112,113], antisense transcript of IL1b and a long intergenic
non-coding RNA (lincRNA) Cox2 [114,115] (Table 2). LincRNA Cox2
was found to have a role in TLR-induced expression of interleukin-6
(Il6) [116]. TNF and HNRNPL-related immunoregulatory lincRNA
(THRIL) were reported to regulate expression of tumor necrosis
factor (TNF) in human monocytes through interactions with
HNRNPL [117,118]. In addition to the phagocytosis and secretion ofTable 2
LncRNA in immunity.
S.N.o. lncRNA Function
1 LincRNA-COX2 Role in TLR-induced expre
2 Lnc-DC Required for the differentia
3 NRON Transcription regulator for
4 Lnc-IL7R Epigenetically regulates in
5 NeST/Tmevpg1 Epigenetically regulates th
6 IL1b-eRNA Overexpressed in LPS indu
7 PACER Involved in multiple proce
8 THRIL regulate expression of tum
9 IL1b-RBT46 Regulates the homeostasis
10 lethe Upregulated during inﬂam
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(2016), http://dx.doi.org/10.1016/j.ncrna.2016.11.002pro-inﬂammatory mediators by macrophages, autophagy is the
most recent mechanism of the immune response to bacterial
infection. Although, the role of lncRNAs in autophagy response to
the intracellular bacteria is still unknown [119], it has been reported
that IFN-g induced autophagy in infected macrophages resulted in
sustained lncRNAMEG3 down-regulation and lack of IFN-g allowed
for counter-regulation of lncRNA MEG3 by viable M. bovis BCG.
Knockdown of lncRNA MEG3 in macrophages resulted in auto-
phagy and enhanced removal of intracellular M. bovis BCG [120,
121]. It has also been reviewed that lncRNAs may have a function
in a variety of human polygenic diseases from cancers of different
organs to non-cancerous diseases, such as Alzheimer's disease
[122e125]. Further research may enable us to better understand
their infectious and inﬂammatory pathologies and may provide a
new insight for effective therapeutics.
5. Conclusion
Despite the fast increase in understanding the functional role of
lncRNA, this ﬁeld is still in its infancy and many questions and
challenges are debatable. Their role in human diseases is a mystery.
Undoubtedly, in this review article we tried to explain how lncRNAsReference
ssion of interleukin-6 [114,115]
tion of monocytes to dendritic cells [93]
immune regulation [112,113]
ﬂammation [96]
e adaptive immunity through IFN-gamma [105,106]
ced inﬂammation [107]
sss related to regulation of immunogene expression [111]
our necrosis factor (TNF) in human monocytes [117]
of IL-1b in monocytes [108]
mation [95]
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ological processes of the cell. A better understanding of chromo-
somal architecture and afﬁliation between the organization of RNA
structure and protein recruitment as well as gene regulation shall
help in prognosis and design novel therapeutics to target gene
expression for the treatment of many dreadful human diseases.
Many of the lncRNAs are reported to have diverse functions, iden-
tiﬁed through genomic and transcriptomic approaches. The Much
deeper study is needed to discover many more lncRNAs that have
their functions annotated. Another challenge in lncRNA research is
to explore their coding prospective. The possibility that code for
short peptides has not been ruled out as of now.References
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